학술논문
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma
Document Type
Article
Author
Source
In Clinical Ovarian Cancer June 2011 4(1):26-33
Subject
Language
ISSN
1941-4390